Development and Initial Validation of a Questionnaire to Measure Health-Related Quality of Life of Adults with Common Variable Immune Deficiency: The CVID_QoL Questionnaire-Reference-Cited by-同舟云学术

Development and Initial Validation of a Questionnaire to Measure Health-Related Quality of Life of Adults with Common Variable Immune Deficiency: The CVID_QoL Questionnaire

Published:2016-11 Issue:6 Volume:4 Page:1169-1179.e4
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Quinti Isabella^ORCID,Pulvirenti Federica,Giannantoni Patrizia,Hajjar Joud^ORCID,Canter Debra L.,Milito Cinzia,Abeni Damiano,Orange Jordan S.,Tabolli Stefano

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference35 articles.

1. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee;Geha;J Allergy Clin Immunol,2007

2. Common variable immunodeficiency disorders: division into distinct clinical phenotypes;Chapel;Blood,2008

3. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency;Busse;J Allergy Clin Immunol,2002

4. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology;Orange;J Allergy Clin Immunol,2006

5. Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease;Roifman;Am J Med,1985

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in health-related quality of life in common variable immunodeficiency: an eight-year journey, including the COVID-19 pandemic;Expert Review of Clinical Immunology;2024-07-12

2. Charting a course for global progress in PIDs by 2030 — proceedings from the IPOPI global multi-stakeholders’ summit (September 2023);Frontiers in Immunology;2024-06-27

3. Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndrome;Blood Advances;2024-06-13

4. Understanding Health Equity in Patient-Reported Outcomes;The Journal of Allergy and Clinical Immunology: In Practice;2024-04

5. UK PID Patients: Overview of perception on IgRT and infections using short survey;PHARMAZIE;2023